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Hematopoietic stem and progenitor cell (HSPC) compartments are altered to direct
immune responses to infection. Their roles during immunization are not well-described.
To elucidate mechanisms for waning immunity following immunization with acellular
vaccines (ACVs) against Bordetella pertussis (Bp), we tested the hypothesis that
immunization with Bp ACVs and whole cell vaccines (WCVs) differ in directing the
HSPC characteristics and immune cell development patterns that ultimately contribute
to the types and quantities of cells produced to fight infection. Our data demonstrate
that compared to control and ACV-immunized CD-1 mice, immunization with an
efficacious WCV drives expansion of hematopoietic multipotent progenitor cells (MPPs),
increases circulating white blood cells (WBCs), and alters the size and composition of
lymphoid organs. In addition to MPPs, common lymphoid progenitor (CLP) proportions
increase in the bone marrow of WCV-immunized mice, while B220+ cell proportions
decrease. Upon subsequent infection, increases in maturing B cell populations are
striking in WCV-immunized mice. RNAseq analyses of HSPCs revealed that WCV and
ACV-immunized mice vastly differ in developing VDJ gene segment diversity. Moreover,
gene set enrichment analyses demonstrate WCV-immunized mice exhibit unique gene
signatures that suggest roles for interferon (IFN) induced gene expression. Also observed
in naïve infection, these IFN stimulated gene (ISG) signatures point toward roles in cell
survival, cell cycle, autophagy, and antigen processing and presentation. Taken together,
these findings underscore the impact of vaccine antigen and adjuvant content on skewing
and/or priming HSPC populations for immune response.
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INTRODUCTION
Innate and adaptive immune cells originate from hematopoietic
stem cells (HSCs). Over an organism’s lifetime, long-term HSCs
(LT-HSCs) self-renew and generate short-term HSCs (ST-HSCs).
ST-HSCs give rise to myeloid and lymphoid progenitors that
differentiate into immune cells (1). Hematopoietic stem and
progenitor cell (HSPC) renewal, expansion, and differentiation
are tightly regulated to produce and maintain sufficient
blood cells (2). Cell–cell interactions, microenvironment
contributions, cytokines, and gene signature changes prompt
HSPC expansion (1, 3). During infection, this results from: (1)
direct pathogen interaction or signals that push differentiation
and/or mobilization or (2) a pull to replenish leukocytes required
for immune surveillance and clearing infection (4, 5). The
immune system critically relies on these events to produce
correct quantities and types of cells required for response
to pathogens and stress (6). At sites of infection, innate and
adaptive arms of the immune system work synergistically to
clear infection and/or prevent recurrence. Long-term immunity
is maintained by antigen-specific memory B and T cells.
Recent evidence suggests that innate immune cells also provide
long-term immunity independently (7–9).
While HSPCs direct immune responses to infections,
little is known about their significance in immunization-
induced immunity (10–17). Kaufmann et al. demonstrated
that Bacillus Camette-Guerin (BCG) vaccination “educates”
HSPCs to form components of innate immunity responsible
for long-term immune protection from tuberculosis (9). Herein,
we demonstrate that vaccine composition influences HSPC
frequency by eliciting a unique transcriptional landscape that
impacts both innate and adaptive immunity. Recent re-
emergence of pertussis, a highly contagious respiratory infection
caused by the Gram-negative bacterial pathogen Bp, prompted
our use of a pertussis model to investigate the roles of HSPCs
in vaccine efficacy. Immunization strategies were altered from
the use of highly efficacious whole cell vaccines (WCVs), such
as DTP, to acellular vaccines (ACV) (DTaP/tdap) in the 1990s.
Evidence suggests that recent increases in pertussis cases are
due in part to waning ACV protection (18–20). Epidemiological
data indicate that when ACVs prevent disease, they may fail to
completely prevent infection or transmission (18, 19). Without
enhanced vaccines, pertussis incidence is expected to continue to
rise, given that a greater proportion of the population over time
will only be ACV-immunized. Because WCVs offer longer-lived
protection (21), comparisons regarding how immune responses
to ACV and WCV differ, including impact on HSPCs, may
provide insight for next generation ACVs that are safe and
efficacious.
To investigate the role of vaccine content on influencing
HSPCs, it is essential to consider known components of each
pertussis vaccine. Despite differences in overall antigenic content,
WCVs, which are inactivated entire Bp organisms, and ACVs,
which contain purified components of Bp, share some common
antigens: pertussis toxin (PT), filamentous hemagglutinin (FHA),
pertactin, and fimbriae. ACVs contain aluminum hydroxide,
which contributes to a T helper (Th)2-polarized response.
Conversely, lipo-oligosaccharide (LOS) in WCVs promotes
Th1/Th17 responses (22) despite DTP combined vaccines’
inclusion of alum. Little is known regarding the influence of
the components of pertussis vaccines on HSPCs. Enzymatically
active PT can induce HSC mobilization by blocking G protein
function (23), but it is inactivated in ACVs and present only
in low concentrations in WCVs (unpublished observations).
Additionally, alum, which is present in ACVs and some WCVs,
is known to induce granulopoiesis (24) while LOS, present only
in WCVs, stimulates TLR4 signaling known to induce HSPC
expansion in bone marrow (25).
In the present study, we tested the hypothesis that vaccine
composition determines immune response by HSPCs. To do so,
we assessed the impact ACVs and WCVs on HSPC expansion,
differentiation, and downstream peripheral immune response.
We demonstrate that WCVs (1) induce HSPC expansion,
priming them for antigen processing and presentation, (2)
increase extramedullary hematopoiesis providing stores of
immature immune cells released by the spleen upon infection,
and (3) prime HSPCs for rapid B cell maturation upon
subsequent Bp challenge. We also show that ACVs have little
impact on HSPCs. This knowledge provides insights into
methods by which immune responses to ACVs andWCVs differ,
thus introducing a novel area of study that may explain in part
why waning immunity occurs with ACVs.
METHODS
Mouse Models
Phosphate buffered saline (PBS), 1/5th human dose of
INFANRIX (GSK) human vaccine (DTap/ACV), or 1/5th
human dose of National Institute for Biological Standards
and WHO International Standard Bp vaccine (NIBSC 94-532)
(WCV) were used to immunize 5-weeks-old female CD-1
mice (Charles River) by intraperitoneal injection (Table S1).
Anesthetized mice were infected by intranasal administration
of 2 × 107 colony forming units (CFU) of Bp strain UT25 (26)
in 20 µl of PBS. Bp was handled using standard biosecurity
and institutional procedures necessary for the use of a BSL-2
microorganism. These procedures were approved by the West
Virginia University Institutional Biosafety Committee (protocol
17-11-01). Post-vaccination and challenge, organs/tissues
were extracted in sterile conditions from mice euthanized
by pentobarbital injection as recommended by the Panel on
Euthanasia of the American Veterinary Medical Association.
Cardiac puncture blood was collected. Serum was separated
by centrifugation using Microtainer blood collection tubes
(BD). Trachea and lungs were homogenized to determine
bacterial burden. For Bp burden in the nares, 1ml of PBS
was flushed through the nares. Serial dilutions in PBS were
plated on Bordet Gengou (BG) Agar containing 15% sheep’s
blood and streptomycin (100µg/ml). Bone marrow extraction
was performed by flushing RPMI media (ATCC) + 10% fetal
bovine serum (FBS) (Sigma) through mouse femurs. Cells were
pelleted by centrifugation (500 g) and red blood cell lysis was
performed by incubating cells in 1ml 1X BD PharmLyse
TM
(BD
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Biosciences) for 2min at 37◦C. Cells were washed in 1X PBS
containing 2% FBS and prepared for flow cytometry. Spleens
were dissociated by being passed through a 70µm mesh filter in
5ml RPMI media (ATCC) + 10% FBS (Sigma) with the aid of
a syringe plunger. Cells were pelleted by centrifugation (500 g)
and red blood cell lysis was performed by incubating cells in
1ml 1X BD PharmLyse
TM
(BD Biosciences) for 2min at 37◦C.
Cells were washed in 1X PBS containing 2% FBS and prepared
for flow cytometry. This study was reviewed and approved by
the West Virginia University Institutional Animal Care and Use
Committee (protocol Damron 14-1211).
Complete Blood Counts and Histology
Complete peripheral blood (PB) counts were analyzed using
a Drew Scientific Hemavet 950. Briefly, a portion of PB
from the cardiac puncture was collected using Microtainer
blood collection tubes (BD) with a K2EDTA additive. After
thorough mixing within the K2EDTA containing tube, blood was
transferred to a 1.5ml microcentrifuge tube and run on the Drew
Scientific Hemavet 950. For tissue histology, tibias and spleens
were fixed in formalin, embedded in paraffin blocks, sectioned,
and stained with hematoxylin and eosin (H&E).
Flow Cytometry
Following Fc receptor blocking in PBS containing 2% FBS, 1 ×
106 cells were incubated in antibody for 1 h at 4◦C in the dark.
Cells were then washed 2 times with PBS, and resuspended in
fluorescence-activated cell sorting (FACS) buffer. Flow cytometry
antibodies (listed in Table S2) were chosen to acquire a broad
understanding of how different vaccine compositions influence
the development of both innate and adaptive immune cells. FACS
analyses were performed on BD LSRFortessa or FACSAria III
cytometers. Data was analyzed using FlowJo_V10.
Cytokine Analysis
Spleen homogenates were pelleted by centrifugation (1,000 g for
5min). Collected supernatant was stored at−80◦C until analysis.
Concentrations of cytokineswere determined by quantitative
sandwich immunoassays, Meso Scale Discovery (Rockville, MD)
V-PLEX Proinflammatory Panel (K15048G-1).
Isolation of RNA, Illumina Library
Preparation, and Sequencing
RNA was prepared immediately using RNeasy purification kits
(Qiagen) and quantified using Qubit 3.0 (ThermoFisher). RNA
integrity was assessed using Agilent BioAnalyzer RNA Pico
chip. Samples were submitted for Ribo-zero rRNA depletion
(Illumina) and reassessed for RNA integrity. Samples were
processed into libraries by the Ovation RNA-Seq System v2
(NuGEN) protocol. Quality control was performed on libraries
using the KAPA qPCR QC assay (KAPA Biosystems). Libraries
(36 total) were sequenced on an illumina HiSeq 1500 at the
Marshall University Genomics Core facility, 2 × 50 bp resulting
in ∼16M reads per sample. Sequencing data was deposited
to the Sequence Read Archive (reference number SRP130256,
BioProject number PRJNA430726).
RNAseq Bioinformatic Analyses
Reads were analyzed using CLC Genomics Workbench 9.5.
Default settings were used for mapping reads against the
GRCm38musmusculus genome. Fold changes in gene expression
and statistical analyses were performed using Extraction of
Differential Gene Expression (EDGE) test on p-values. Venn
diagrams and gene set enrichment were established using Venny
2.1 (27) and PANTHER, respectively. Significant data was
determined by FDR (<0.05). In Ingenuity Pathway Analysis
(IPA), significant genes (p < 0.05) were uploaded into software
and datasets were compared across immunization and challenge
conditions. IPA’s Upstream Regulator analytic was utilized to
identify upstream transcriptional regulators.
Immunoglobulin and B- and T-Cell
Receptor Profiling
B cell clones were identified using MiXCR software
(MiLabratory) (28), capable of generating quantitated clonotypes
of immunoglobulins. Reads were merged using concatenation
and imported into MiXCR software and aligned to each other to
generate clonotypes based on Variable (V), Diversity (D), and
Joining (J) (VDJ) segment regions of unique immunoglobulins
specific to each sample. Clone data was grouped based on
vaccine received and time point. Clonotypes were separated
into T and B cells based on T-cell receptor or B-cell receptor
specific sequences. Prepared data files were imported into
VDJtools (MiLabratory) for data representation as previously
described (29).
Statistical Analysis
Results are depicted asmean± SEM. Excluding RNAseq statistics
described above, all other statistical analyses were performed
using two way ANOVAs and Tukey’s multiple comparisons.
GraphPad Prism software was used for statistical analysis.
RESULTS
Vaccine Content Determines Peripheral
Immune Response to Bp Challenge
To investigate how vaccine impact on HSPCs contributes to
immunity to pertussis in CD-1 outbred mice, we utilized a
vaccination and challenge workflow (Figure 1A) for profiling
immune responses after primary and boost immunizations as
well Bp challenge. Five-weeks-old mice were immunized with
PBS (vehicle control), ACV, or WCV (Table S1), boosted, and
subsequently challenged with Bp. Although ACVs wane in
immune protection over time in humans (18–20), short-term
experiments in mice show similar initial clearance of bacterial
burden in sites of respiratory infection (lung, nasal wash, and
trachea) in both groups (Figure 1B) with 1/5th human doses.
Serological analysis of Ig(A+G+M) indicates that only the
ACV induces detectable anti-PT, whereas both the ACV and
WCV induce anti-FHA. As expected, the LOS-containing WCV
induces production of anti-LOS (serology data not shown).
To demonstrate consistency of our model with other groups,
we assessed PB cell counts. Pertussis causes leukocytosis in
humans, rodents, and baboons (30–32), andWCV immunization
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FIGURE 1 | Vaccine content determines PB immune response to Bp challenge. (A) The workflow for immunization and infection schedules of 5-weeks-old female
CD-1 mice is represented. Mice were immunized with phosphate buffered saline (PBS), Bp acellular vaccine (ACV), or Bp whole cell vaccine (WCV) and infected with 2
× 107 CFU UT25 Bp. Immune responses in mice were evaluated at 1 and 3 days after immunization, boost, and infection. (B) Bp bacterial burden was measured in
lung, nasal wash, and trachea of mice (n = 4–8/group for each time point) by counting CFUs produced 3 days after plating and incubating serial dilutions of
homogenates on BG containing streptomycin (100µg/ml) at 37◦C. (C) White blood cell counts were measured (n = 5–6/group for each time point) on a Drew
Scientific Hemavet 950 at days 1 and 3 post-immunization and days 1 and 3 post-infection **p < 0.01; ***p < 0.001. (D) Differential white blood cell counts measured
on days 1 and 3 post-immunization are represented. *p < 0.05; 2-way ANOVAs with Tukey’s multiple comparisons. Bars extend to represent minimum to maximum
values, while the line represents the mean.
has been shown to also result in leukocytosis (33). Our WCV-
immunized mice exhibit increases in white blood cells at
day 3 post-immunization when compared to PBS and ACV-
immunized mice. WBCs increase again following subsequent
infection (day 1) (Figure 1C) in WCV-immunized mice.
Increases in WBCs are attributed to increased myeloid
cells, particularly neutrophils and monocytes (Figure 1D).
Mimicking Bp infection, our WCV immunization model induces
leukocytosis in response to immunization. These data directed
our attention to upstream events leading to WBC responses.
WCV Content Alters the Size and
Composition of Peripheral Lymphoid
Organs
To determine how each vaccination further effects the periphery,
evaluations of lymphoid organs were performed. Two major
lymphoid organs, which defend the body against invading
pathogens include the thymus and the spleen. Thymus and spleen
weights were recorded throughout our experimental schedule.
Though only minor differences occur between vaccination
groups in thymus weight and cell population proportions (data
not shown), spleen sizes (Figure S1A), and weights (Figure 2A)
increase progressively post-immunization with the WCV when
compared to other groups. Cell counts following RBC lysis
confirm increased spleen cellularity in WCV-immunized mice
(data not shown). Spleens then decrease dramatically and rapidly
in size and weight (2.45-fold) upon Bp infection (Figure S1A and
Figure 2A), suggesting that cells migrate from the spleen to sites
of infection. Similarly, naïve infected mice also exhibit decreases
in spleen weight (1.94-fold) upon infection, but this occurrence
is delayed when compared to WCV-immunized mice. Naïve
mice exhibit a reduction in spleen weight 3 days post-infection,
whereas WCV-immunized mice exhibit reduced spleen weight
at 1 day post-infection. By day 3 post-infection spleen sizes
are beginning to increase again in WCV-immunized mice. Flow
cytometric analysis of splenocytes revealed that CD11b+GR-
1+ myeloid cell proportions (Figure S1B and Figure 2B) are
significantly increased in WCV-immunized mice, suggesting
that they contribute to increased spleen size. CD11b+GR-
1+ cells comprise a heterogeneous population of myeloid
cells including myeloid progenitors, immature macrophages,
immature granulocytes, and immature dendritic cells (34).
WCV-immunized mice display proportional decreases in
splenic CD3e+ T cells (post-immunization day 3, post-boost
day 3, and post-infection day 3 and B220+ B cells (post-boost
days 3 and 12) (Figures 2C,D). To determine if proportional
decreases were due only to reflect the increased myeloid cells in
the spleen, total B and T cells were assessed in the spleen at days
1 and 3 post-immunization and post-infection (Figures S1C,D).
Total B cells do not differ between groups post-immunization. T
cell proportional decreases in WCV-immunized mice, however,
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FIGURE 2 | WCV content induces alterations in the size and composition of peripheral lymphoid organs suggesting extramedullary hematopoiesis may occur. (A)
Spleen weights from CD-1 mice (n = 4/group for each time point) immunized with phosphate buffered saline (PBS), Bp acellular vaccine (ACV), or Bp whole cell
vaccine (WCV) were recorded at the indicated time points across the immunization and infection schedule. (B) CD11b+Gr-1+ cell proportions in the spleen
(n = 4/group for each time point) were measured by flow cytometric analysis. (C) CD3e+ cell proportions in the spleen (n = 4/group for each time point) were
measured by flow cytometric analysis. (D) B220+ cell proportions in the spleen (n = 4/group for each time point) were measured by flow cytometric analysis. (E)
Representative images were taken of H&E-stained spleen (n = 4/group) at 400X magnification. (F) IL-1β in spleen homogenate (n = 4/group) was measured by
quantitative sandwich immunoassays. G. Proportions of lineage−c-kit−Sca-1+ cells in the spleen (n = 4/group for each time point) were measured using flow
cytometric analysis. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; 2-way ANOVAs with Tukey’s multiple comparisons. Error bars are mean ± SEM values.
are due in part to a decrease in total T cells at day 3 post-
immunization. Upon subsequent infection (day 3), however,
CD3e+ T cells are present in higher proportions and total
numbers in the spleen in PBS and WCV-immunized mice
when compared to ACV-immunized mice (Figure S1C and
Figure 2C). Interestingly, as myeloid cell proportions become
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similar to PBS and ACV-immunized mice following infection,
both T and B cells are increased in total number in the spleen. To
further elucidate to impact of immunization formulation on cell
population dynamics and cellularity in the spleen, H&E staining
of spleen cross sections (day 3 post-vaccination) were performed.
This examination of histology confirms hypercellularity and
increases in myeloid cells, including megakaryocytes, occurs
in WCV-immunized mice when compared to other groups
(Figure 2E).
Parallel to increases in myeloid cell proportions in the spleens
of WCV-immunized mice, on post-immunization day 3, we
observed a significant increase in splenic IL-1β production
(Figure 2F). IL-1β, which is produced by myeloid cells, enhances
lymphocyte processes such as antigen-primed CD4 and CD8 T-
cell expansion, differentiation, and migration to the periphery as
well as memory (35, 36). Additionally, on post-immunization day
3, when compared to PBS and ACV groups, WCV-immunized
mice exhibit larger proportions of splenic Lineage−Sca-1+c-
Kit− cells (Figure 2G), which have been described as lymphoid
progenitor cells that expand in the spleen upon infection,
preferentially maturing into B cells (37, 38). Taken together,
these data suggest that extramedullary hematopoiesis, which
can occur due to mobilization of bone marrow HSPCs to the
spleen (39, 40), is expanded in WCV immunizations. Evidence
gathered from kinetics of immature cell population changes
in the spleen suggest that bone marrow HSPC compartment
composition may play a role in splenic immune response to
vaccination.
WCV Immunization Induces MPP
Expansion in the Bone Marrow
All groups evaluated have a similar level of cellularity in
the bone marrow following infection as evidenced by H&E
staining of lengthwise cross-sections of tibia (Figure 3A) and
total cell counts (data not shown). Flow cytometric analysis
of bone marrow HSPCs demonstrates that Lineage-Sca-1+c-
Kit+ (LSK) cell proportions increase in WCV-immunized
mice when compared to PBS and ACV-immunized mice
(Figures 3B,C). Interestingly, naïve mice elicit robust delayed
LSK expansion upon Bp challenge (Figure 3B). Further analysis
of LSK cells in WCV and naïve challenge indicate that the
expanded LSK are CD48+CD150− multipotent progenitor cells
(MPPs) (Figure 3D). To gain insight into how proportions
of these progenitors change among groups when compared
to proportions of other populations, LT-HSC, ST-HSC, MPP,
common lymphoid progenitor (CLP), common myeloid
progenitor (CMP), granulocyte monocyte progenitor (GMP),
and megakaryocyte erythrocyte progenitor (MEP) bone marrow
populations were analyzed to be presented as parts of the whole
HSPC compartment (Figure 3E). Major differences in HSPC
proportions occur across vaccine groups. WCV-immunized
mice exhibit large proportions of MPPs upon initial vaccination
(day 1) and boost (day 1) that become reduced with time after
each incidence (day 3 post immunization and boost), while
ACV-immunized mice exhibit MPP proportions only slightly
larger than those of PBS control (day 1 post-immunization,
day 1 post-boost). It is evident that WCV-immunized mice
post-vaccination (day 1) highly resemble naïve infection (PBS)
post-challenge (day 3).
WCV Immunization Primes Bone Marrow
HSPCs for Rapid Maturation of Developing
B Cells Upon Subsequent Infection
In WCV-immunized mice, Lineage−Sca-1−c-kit+ (LK) cell
proportions are decreased upon boost and infection when
compared to other groups (Figure 4A). Further analysis
into the cell populations that comprise LK cells revealed a
proportional decrease within WCV-immunized mice in MEP
populations post-immunization (day 3) and post-infection (day
1) (Figures 4C,D). Regarding lymphoid progenitors, an increase
in CLP proportions upon infection is observed in WCV-
immunized mice (Figure 4C). Aside from B cells, no mature
populations evaluated differed across groups (data not shown).
B220+ cell proportions, however, were reduced significantly in
WCV mice post-immunization (day 3) and post-boost (day 3)
(Figure 4C). Interestingly, post-infection (day 3), B220+ cells
in WCV-immunized mice showed signs of robust maturation
processes (Figure 4E). Our data indicate that HSPC expansion
in response to immunization and infection is a dynamic process,
which prompted us to investigate the transcriptomic profiles of
HSPCs to better understand the mechanisms and systems driving
observed responses.
RNAseq Analysis of Developing VDJ
Recombination in HSPCs
To characterize gene expression profiles of HPSCs in relation to
immunization and challenge, HSPCs were isolated from the bone
marrow of mice upon immunization and infection. Isolated RNA
was converted into libraries for Illumina platform sequencing.
We obtained expression data for ∼60% of all encoded murine
genes across all experimental groups (Table S3) indicating robust
transcriptomic analysis. Since differential expansion of bone
marrow B cell populations occurs in response to immunization
(Figure 4), we hypothesized that B cell population dynamics
coincide with differential VDJ recombination developing within
HSPCs. VDJ recombination and somatic hypermutation during
B cell development and affinity maturation are responsible for
diversity of antigen-recognizing B cell receptors (BCRs). Highly
variable complementarity determining region 3, which plays
a critical role in antigen specificity and binding affinity, is
located at the VDJ junction BCR heavy chains (41). Mapped
reads were analyzed with MiTCRx and VJRtools to identify
immunoglobulin sequences, building libraries of clonal types.
Figure 5A shows resulting B cell repertoires for all immunization
and infections conditions. Spectral plots show that both ACV
and WCV immunization influence clonal populations compared
to naïve (PBS) mice. Post-immunization (day 3), these clone
repertoires return to a state more similar to naïve mice. Upon
infection, the clone repertoires diversify and it becomes difficult
to distinguish naïve infected or immunized groups. Investigation
of per clone diversity revealed that only the WCV group exhibits
enhanced amounts of any one clone. The IGKV15-103/IGKJ4
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FIGURE 3 | WCV immunization induces MPP expansion in the bone marrow. (A) Representative images of cross sections of tibia from CD-1 mice (n = 4/group for
each time point) immunized with phosphate buffered saline (PBS), Bp acellular vaccine (ACV), or Bp whole cell vaccine (WCV) and infected with 107 CFU Bp were
taken at 400X magnification. (B) Proportions of lineage−Sca-1+ckit+ (LSK) cells were evaluated in the bone marrow (n = 4/group for each time point) using flow
cytometric analysis. (C) Representative dot plots of the flow cytometric analysis from 3B are shown. (D) Representative dot plots from further gating on LSK
proportions to show CD48 and CD150 biexponential plot. (E) Hematopoietic stem and progenitor cell proportions were analyzed by flow cytometry and are
represented as parts of the whole. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; 2-way ANOVAs with Tukey’s multiple comparisons. Error bars are mean ±
SEM values.
clone was enriched in HSPCs from WCV-immunized mice
and WCV-immunized mice that were subsequently infected.
We speculate that this clone may be responsible for anti-LOS
which is produced in high quantities in WCV-immunized mice.
Enlarged spectral plots with labeled clones can be found in
Figures S2–S4.
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FIGURE 4 | WCV immunization prepares HSPCs for rapid maturation of developing B cells upon subsequent infection. (A) Proportions of lineage−Sca-1+ckit+ (LK)
cells were evaluated in the bone marrow of CD-1 mice (n = 4/group for each time point) immunized with phosphate buffered saline (PBS), Bp acellular vaccine (ACV),
or Bp whole cell vaccine (WCV) and infected with 107 CFU Bp using flow cytometric analysis. (B) Proportions of megakaryocyte erythroid progenitors (MEPs) and
common lymphoid progenitors (CLPs) were evaluated in mouse bone marrow (n = 4/group for each time point) post-immunization and (C) post-infection by flow
cytometric analysis. (D) Proportions B220+ cells were evaluated in mouse bone marrow (n = 4/group for each time point) using flow cytometric analysis. (E)
Representative dot plots from further gating on cells from part D are shown. *p < 0.05; **p < 0.01; ****p < 0.0001; 2-way ANOVAs with Tukey’s multiple comparisons.
Error bars are mean ± SEM values.
Immunization and Infection Induces
Unique Gene Expression Profiles of HSPCs
RNA sequencing (days 1 and 3 post-immunization, and days
1 and 3 post-infection) demonstrates that HSPCs respond
to WCV-immunization by altering many immune response
gene signatures. WCV-immunized mice exhibit >19-fold
more differentially expressed genes when compared to
ACV-immunized mice (Figure S5A). The most enriched
of 18 significant gene signatures (fold change > 5) in
this WCV HSPC gene set include protein folding, antigen
processing and presentation, and response to interferons (IFNs)
(Figure S5B). Genes differentially expressed only in HSPCs of
ACV-immunized mice as well as genes differentially expressed in
both immunization groups yielded no significantly enriched gene
signatures.
Differential gene expression between vaccine groups upon
challenge with Bp reveals that 35 genes overlap all groups,
88 genes exhibit unique overlap of naïve infection (PBS-
immunized) and WCV, while 9 genes overlap ACV and
naïve infected mice (Figure S5C). Enrichment of 123 genes
differentially expressed in HSPCs from naïve infected mice that
do not overlap with other groups resulted in signatures involving
phagocytosis, complement, regulation of B cell activation,
defense response to bacterium, and innate immune response
(Figure S5D). Enrichment of genes uniquely overlapping
naïve infection and WCV-immunized, Bp-infected mice
produce similar defense response signatures (Figure S5E),
but additionally include MHC class I and II processing and
presentation and response to IFNs. No enriched pathways exist
for differentially expressed genes that overlap naïve infection
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FIGURE 5 | Vaccine content drives the transcriptional landscape of HSPCs. (A) Pairwise overlap circos plots of HSPC B cell clonal repertoires (n = 6mice/group) were
prepared using MiXCR software. Count, frequency and diversity panels correspond to the read count, frequency (both non-symmetric) and the total number of
clonotypes that are shared between samples. Pairwise overlaps are stacked, i.e., segment arc length is not equal to sample size. (B) A heatmap was prepared to
represent the top 50 differentially expressed genes downstream of IFNα, β, and/or γ across all immunization and infection groups. Day 1 for immunization and
infection is shown below the dark blue text, while day 3 is shown below the magenta text. Gene sets for the heatmap were prepared using IPA’s Upstream Regulator
analytic tool. RNA was pooled from 2 mice for each sample n.
and ACV-immunized, Bp-infected mice. Additionally no
enriched pathways exist for gene sets unique to WCV or ACV.
Analysis of 35 genes overlapping all infection groups presents
8 significant gene signatures that resemble those observed in
WCV immunization only (Figure S5F). Direct comparisons
of initial immunization to naïve infection reveal that gene
signature responses in HSPCs upon naïve infection resemble
those of WCV-immunized, non-challenged mice as well. These
include IFN response, MHC class I and II molecule production,
chaperone folding, and immunoproteasome formation (data
not shown), suggesting increased antigen processing and
presentation.
Further highlighting mechanisms driving these immune
responses, powerful algorithms and advanced analysis
capabilities available through IPA allowed for the identification
of transcriptional patterns that indicate a significant role
for IFN stimulated gene (ISG) expression in HSPCs from
WCV-immunized mice when compared to ACV-immunized
mice. Z-scores, used to infer the activation state of predicted
upstream transcriptional regulators, were increased in HSPCs
from WCV-immunized mice for upstream IFNα, IFNβ,
and IFNγ signaling when compared to ACV-immunized
HSPCs. Similar to immunization, naïve infection and
challenged WCV-immunized mice exhibited increased
activation of these pathways compared to ACV-immunized
mice. A heatmap displaying the top 50 differentially
expressed IFN (α, β, and γ) stimulated genes is shown in
Figure 5B.
Our proposed model for vaccine content influence on HSPCs
through IFN signaling pathways is described in Figure 6. Briefly,
we have propose that following vaccination with ACV, similar
to PBS—immunized mice, cytokines in the PB impact the bone
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FIGURE 6 | Proposed model for vaccination and infection effects on HSPCs and downstream immune response. Following vaccination with ACV, similar to PBS
(negative control) immunized mice, cytokines in the peripheral blood impact the bone marrow microenvironment to produce immune cells. Following vaccination with
WCV, IFNs are produced and circulate in the blood, impacting the bone marrow microenvironment, thereby directing an expansion of HSPCs. In addition to HPSC
proportional expansion, mature B cells decrease proportionally within in the bone marrow, while all other immune cells analyzed (T cells, macrophages, and
granulocytes) do not significantly change. Given that bone marrow cellularity remains similar to PBS and ACV immunization groups, we hypothesize that upon
production, select progenitors and differentiated cells move out of the marrow and into the peripheral blood where they migrate to the spleen. Upon subsequent
infection, HSPCs undergo expansion again and cells in the peripheral blood and spleen migrate to sites of infection to clear Bp. During naïve infection, a similar
process occurs. This model was created using BioRender.
marrow microenvironment to produce immune cells required
for homeostasis. Following vaccination with WCV, however,
we speculate that additional IFNs are produced and circulate
in the blood, impacting the bone marrow microenvironment,
thereby directing an expansion of HSPCs. In addition to HPSC
proportional expansion, we observe that mature B cells decrease
proportionally within in the bone marrow, while all other
immune cells analyzed (T cells, macrophages, and granulocytes)
do not significantly change. Given that bone marrow cellularity
remains similar to PBS and ACV immunization groups, we
hypothesize that upon production, select progenitors and
differentiated cells move out of the marrow and into the PB
where a subset of these cells migrate to the spleen. Upon
subsequent infection, HSPCs undergo expansion again and
cells in the PB and spleen migrate to sites of infection to
clear Bp. During naïve infection, a similar process occurs. We
propose that immune cell activation in the periphery results
in IFN signaling that reaches HSPCs of the bone marrow,
inducing ISG expression and influencing cell cycle, survival,
autophagy, and innate immune signaling pathways among
others.
DISCUSSION
Investigating the impact of altered HSPC populations following
immunization is imperative to advancing knowledge that will
inform the design of future vaccines. We have described
how content of pertussis vaccines influences HSPC population
kinetics and associated peripheral immune responses. While
WCVs or ACVs allow mice to clear short-term infection,
longevity of immune protection may reside in how HSPCs are
influenced following immunization. This includes the propensity
of these cells to undergo expansion and priming for future
infection responses. Our data indicate that LSK cell populations
are increased in the bonemarrow followingWCV immunization.
This phenomenon mimics how LSK cells are impacted in
response to naïve infection. HSPCs have the capacity to
differentiate into all types of immune cells, and their expansion
following immunization with an efficacious vaccine or naïve
infection correlates with immune cell population changes in the
PB and organs. Further investigation of the HSPC compartment
revealed that LSK expansion is largely due to an increase inMPPs.
Since MPPs support the generation of all types of mature blood
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cells, it is not surprising to find that cell populations of both
myeloid and lymphoid lineages are altered in the bone marrow,
blood, or spleen.
Lymphoid progenitor cell population increases in the bone
marrow and spleen following WCV immunization suggest that
greater proportions of B and T cells are undergoing early stages of
development following WCV immunization when compared to
PBS and ACV immunization. Furthermore, cytokines produced
by the multitude of myeloid cells in the blood and spleen
could impact the way in which these developing lymphocytes
differentiate. Future studies will include kinetics of B and T
cell development for several weeks following immunization.
Regarding immature myeloid cell population increases in the
spleen following immunization, these cells most likely produced
by extramedullary hematopoiesis, seem to act as a reservoir,
poised to move out to the respiratory tract upon subsequent
infection.
In revealing molecular mechanisms responsible for HSPC
alterations and downstream immune cell population changes
observed, transcriptional signatures from HSPCs isolated
from WCV immunization and naïve infection fall into
interesting immune-related gene families. Involved in autophagy,
immunoproteasome formation, molecular chaperone processes,
and class I and class II MHC molecule components, these
gene families suggest that HSPCs may be primed for antigen
presentation. Taken together with the dynamics of B cell
development and developing VDJ recombination within HSPCs,
these data support a role for HSPC involvement in influencing
long-term immune protection via impact on MHC class II
antigen presenting B cell development.
The most striking gene expression change observed in
infection andWCV immunization, but not acellular vaccination,
involves IFN-inducible genes (Figure 5B). Type 1 and 2
IFNs are known for inducing HSC proliferation, which
potentially explains bone marrow HSPC expansion (42–44).
Essers et al. showed that in response to IFNα treatment,
HSPCs exhibit increased Sca-1 and phosphorylation of STAT1
and PKB/Akt. Furthermore, they and others established that
STAT1 and Sca-1 mediate IFNα-induced HSC proliferation. We
speculate that signaling cascades downstream of IFNs, such
as mTOR, PI3K, MAPK, and NFκB pathways, which are all
affected in our datasets, influence HSPC frequency observed
in our models. Beyond impacting cell survival, proliferation,
and cell cycle, many IFN-regulated genes implicated in
our data are involved in immune response. The immunity-
related guanosine triphosphatase (IRG) family, for example,
has well-documented roles in clearing infection (45, 46).
Among other mechanisms, IRGs interfere with infectious
pathogens by disrupting phagocytic vacuoles during infection
(45, 46).
Of the IRG family, 47-kDa GTPases in mice include:
Irgm1, Irgm2, Ifi47, Tgtp1, Tgtp2, Igtp1, and Igtp2, all of
which are upregulated in naïve Bp infection and WCV
immunization against Bp. Genetic deletion of 47-kDa GTPases
severely impairs defense against many primarily intracellular
pathogens: Toxoplasma gondii, Trypanosoma cruzi, Leishmania
major, Listeria monocytogenes, Mycobacterium spp., including
Mycobacterium tuberculosis and Mycobacterium avium,
Salmonella typhimurium, and murine cytomegalovirus (46).
Host immune clearance of intracellular pathogens is relies
upon IFN-mediated cellular immunity(47). Though Bp
is primarily considered an extracellular pathogen, it has
also been shown to survive inside respiratory epithelial
cells, human polymorphonuclear leukocytes, and human
monocytes/macrophages (48–50). Moreover, Connelly et al.
provided evidence that INFγ-induced GTPases play a role
in PT-associated responses in the lungs during Bp infection
(51). Though IFNγ is responsible for many immune responses
(47), it has recently gained much attention in how it mediates
GTPases to eliminate pathogens that survive inside of a cell.
Mitchell et al. has reviewed the processes of immune clearance
of intracellular microorganisms that particularly involve IFNγ
GTPases (52). The two systems discussed (1) xenophagy and
(2) interferon-regulated GTPase promotion of the rupture
of pathogen-containing vacuoles and microbial degradation
are thought to participate in cross-talk that balances the
killing of pathogens within cells and inflammatory responses.
Beyond this, methods by which GTPases are involved in
protection against pathogens include: (1) trafficking from
the endoplasmic reticulum and Golgi to phagosomes, (2)
regulating survival of infected host cells, and (3) regulating
pools of effector lymphocytes (45, 46). It has been proposed
that when coupled with signals from Toll-like receptors, such
as those recognizing LOS, the p47 GTPase family provides an
enhanced sensory system for recognizing infectious agents as
well (53).
Regarding HSPCs, genetic deletion of Irgm1, for which
IRGM is a human ortholog, results in pancytopenia due to
inadequate cell expansion when challenged with mycobacterium
or T. cruzi (54, 55). Given that we observe high expression of
IRG genes during HSPC expansion and robust enrichment of
IFN- and STAT1-related genes in HSPCs of both naïve infection
and WCV immunization, it can be argued that IFN influence
on primitive hematopoietic cells is important in expanding
bone marrow HSPCs for the promotion of leukocytosis.
Feng et al. described an Irgm1 feedback mechanism in Th1
response that promotes antimicrobial function while limiting
detrimental effects of IFNγ on effector T lymphocyte survival
(56). Perhaps similarly, this and other GTPases upregulated in
HSPCs following infection andWCV immunization are involved
in peripheral expansion of immune effector cell populations
during downstream Th1 responses to intracellular pathogens.
Experts in the pertussis field often contribute WCV efficacy to
preferential production of Th1 responses to Bp (57–60). We
speculate that this is partly maintained by upregulated IRGs
within HSPCs.
Relevant to our data, IRGs are also implicated in B cell
maturation. IFNγ induces pre-B cells to exhibit surface
immunoglobulin (61). Simultaneously, IFN-inducible GTPases
increase in expression (61). We postulate that IFN signaling
during efficacious vaccination mimics naïve infection, leading
to various processes that impact HSPCs, including increased
IFN-induced GTPase expression, increased priming of cells for
antigen presentation, and skewed MPP and B cell maturation
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patterns. Similar to our studies, Kaufmann et al. found
IFN signaling to be essential to LSK expansion following
BCG vaccination. In their studies, it was needed to educate
macrophages to provide long-term innate immune protection.
Our work, together with additional studies in trained immunity
(7–9), demonstrates that understanding the mechanisms by
which IFN signaling may prime HSPCs to react to specific
pathogens once cells have matured is underappreciated,
offering a novel area of investigation regarding long-term
immunity.
We expect this work highlighting the importance of vaccine
content in influencing HSPC characteristics to provide new
insights for the development of future pertussis vaccines
as well as provide broad applicability to vaccine efficacy.
Acellular pertussis vaccines protect mice against challenge in
short term immunization/boost/challenge studies. Similarly, in
humans, DTaP performed well in short-term clinical trials
in Europe (62). However, with time it is clearly appreciated
that DTaP/Tdap immunity wanes. We appreciate that there
are substantial differences between murine models and human
hosts. In the present study, however, we aimed to characterize
HSPC expansion on the transcriptomic level. By identifying
biomarkers that can be measured as a function of HSPC
expansion, we may be able to develop protocols to better
monitor early events in immunization for the purpose of
developing vaccine formulations that induce longer term
memory.
We hypothesize that the use of adjuvants that induce
IFN responses and/or TLR4 signaling will enhance ACVs by
influencing HSPC priming and expansion. Our future work
with the use of rationally designed, functionally diverse lipid
A adjuvants (63) will provide answers as to how induction
of HSPC expansion in ACV-immunized mice may contribute
to downstream immune responses. Once we have elucidated
how these adjuvants may enhance vaccine-induced immunity in
mice and other animal models, we expect that this knowledge
will lead to improved ACV vaccines for use in humans.
Furthermore, in future studies we expect to determine how
pertussis immunization and subsequent infection impacts overall
HSPC health and longevity.
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Figure S1 | WCV induces alterations in spleen size and B and T cell population
composition. (A). Spleen sizes from CD-1 mice (n = 4/group for each time point)
immunized with phosphate buffered saline (PBS), Bp acellular vaccine (ACV), or
Bp whole cell vaccine (WCV) are shown in representative images for the indicated
time points across the immunization and infection schedule. (B). Representative
dot plots from flow cytometric analysis described in Figure 2B. (C). Total CD3e+
cells in the spleen (n = 4/group for each time point) were calculated by multiplying
the percentage of CD3e+ live cells (Figure 2C) in the spleen by total number of
live cells in the spleen. (D) Total B220+ cells in the spleen (n = 4/group for each
time point) were calculated by multiplying the percentage of B220+ live cells in the
spleen (Figure 2D) by total number of live cells in the spleen. ∗p<0.05; ∗∗p<0.01;
∗∗∗p<0.001; ∗∗∗∗p<0.0001; 2-way ANOVAs with Tukey’s multiple comparisons.
Error bars are mean ± SEM values.
Figure S2 | Enlargement of controls for the transcriptional landscape of HSPCs B
cell clonal repertoires. Pairwise overlap circos plots of HSPC B cell clonal
repertoires (n = 6mice/group) prepared using MiXCR software and shown in
Figure 5A were enlarged for viewing individual clones. Count, frequency and
diversity panels correspond to the read count, frequency (both non-symmetric)
and the total number of clonotypes that are shared between samples. Pairwise
overlaps are stacked, i.e., segment arc length is not equal to sample size.
Figure S3 | Enlargement of the post-immunization transcriptional landscape of
HSPCs B cell clonal repertoires. Pairwise overlap circos plots of HSPC B cell
clonal repertoires (n=6mice/group) prepared using MiXCR software and shown in
Figure 5A were enlarged for viewing individual clones. Count, frequency and
diversity panels correspond to the read count, frequency (both non-symmetric)
and the total number of clonotypes that are shared between samples. Pairwise
overlaps are stacked, i.e., segment arc length is not equal to sample size.
Figure S4 | Enlargement of the post-infection transcriptional landscape of HSPCs
B cell clonal repertoires. Pairwise overlap circos plots of HSPC B cell clonal
repertoires (n = 6mice/group) prepared using MiXCR software and shown in
Figure 5A were enlarged for viewing individual clones. Count, frequency and
diversity panels correspond to the read count, frequency (both non-symmetric)
and the total number of clonotypes that are shared between samples. Pairwise
overlaps are stacked, i.e., segment arc length is not equal to sample size.
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Figure S5 | Vaccine content determines gene set enrichment of HSPCs. RNAseq
was performed on HSPCs isolated from CD-1 mice on days 1 and 3 post
immunization with PBS, ACV, or WCV and on days 1 and 3 post subsequent
infection with Bp. (A) Venn diagram was prepared for significant differentially
expressed genes in HSPCs of ACV- and WCV-immunized mice when compared
to PBS control mice. (B) Gene signatures enriched (fold change>5) in the
WCV-immunized HSPC gene set are shown. (C) A Venn diagram was prepared
for significant differential gene expression in HSPCs from PBS-, ACV-, and
WCV-immunized and subsequently Bp challenged mice when compared to PBS
control mice. (D). Gene signatures enriched (fold change>5) in the PBS
vaccinated, Bp challenged HSPCs gene set are shown. (E) HSPC gene
signatures enriched (fold change>5) that overlap PBS vaccinated, Bp challenged
and WCV-immunized, Bp challenged mice are shown. (F). HSPC gene signatures
enriched (fold change > 5) that overlap all Bp challenged mice are shown. Venn
diagrams and gene set enrichment were established using Venny 2.1 and
PANTHER, respectively. Significant data was determined by FDR (<0.05).
Table S1 | Compositions of vaccines of this study.
Table S2 | Flow cytometry antibodies used in this study.
Table S3 | Summary of RNAseq performed in this study.
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